Patient subgroups | Learnt rules | ||||
---|---|---|---|---|---|
Profile # | Number of patients | For type of treatment (instances; confidence rate) [rule precision] | For pharmaco- therapeutic class (instances; confidence rate) [rule precision] | For INN (instances; confidence rate) [rule precision] | For Dose (instances; confidence rate) [rule precision] |
3 | 7 | Diet and exercise (7;1) [100%] | Not applicable | ||
4 | 51 | Monotherapy (45;1) [100%] | sulfonylurea if dyslipidemia (7;0.89), else alpha glucosidase inhibitors if not already under biguanides (3;0.8); biguanides by default (11;0.92) [100%] | ||
5 | 59 | Bitherapy (56;1) [100%] | Biguanides and sulfonylurea [100%] | Metformine and gibenclamide [100%] | |
6 | 16 | Insulin [+OAD]** if cholesterolemia ≤ 400 mg/dl (2;0.75), Tritherapy if not (12;0.93) [100%] | Biguanides, sulfonylurea and alpha glucosidase inhibitors if tritherapy [100%] | ||
7 | 84 | Insulin [+OAD]** (75;1) [100%] | Insulin only if already under insulin plus biguanides (62;0.65); Insulin with biguanides if postprandial glycemia >184 mg/dl and age<52 yrs (11;0.92); Insulin with sulfonylurea and alpha glucosidase inhibitors if already under sulfonylurea (11;0.63) [100%] | ||
12 | 1 | Oral bitherapy (mentioned in the guideline) | Biguanides and sulfonylurea [100%] | ||
13 | 39 | Oral bitherapy (mentioned in the guideline) | Biguanides and sulfonylurea if bitherapy [100%] | ||
14 | 18 | Insulin [+OAD]** (mentioned in the guideline) | |||
15 | 18 | Insulin [+OAD]** if morning glycemia >230 mg/dl (8;0.8), tritherapy if not (10;0.92) [100%] | Biguanides, sulfonylurea and alpha glucosidase inhibitors if tritherapy [100%] | ||
16 | 123 | Insulin [+OAD]** (114;1) [100%] | Insulin only if already under insulin plus sulfonylurea or insulin only (72;0.78); Insulin plus biguanides if already under insulin plus biguanides (24.5;0.83); insulin plus biguanides and sulfonylurea if not (17;0.36) [90.9%] | One injection of Insulin if accompanied by biguanides or sulfonylurea (10;0.83); Two injections of insulin [+OAD]** (104;0.79) [72.7%] |